Angiogenesis and prostate cancer: Identification of a molecular progression switch

Keyphrases

• Prostate Cancer 100%
• Angiogenesis 100%
• Molecular Progression 100%
• Cancer Identification 100%
• Vascular Endothelial Growth Factor Receptor (VEGFR) 60%
• Molecular Events 40%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 40%
• Transgenic Adenocarcinoma of Mouse Prostate 40%
• Angiogenic Switch 40%
• PECAM-1 40%
• Hypoxia-induced factor-1α 40%
• In Situ Analysis 40%
• Decreased Expression 20%
• Intraepithelial Neoplasia 20%
• Poor Differentiation 20%
• Tumor Progression 20%
• Vasculature 20%
• Vascular Endothelial Growth Factor 20%
• CD31 20%
• Cancer-related 20%
• Tumor Grade 20%
• Autochthonous 20%
• Immunoblot 20%
• Tissue Specimens 20%
• Prostate Tissue 20%
• Microvessel Density 20%
• Switching Model 20%
• Antiangiogenic Therapy 20%
• Intraductal 20%
• Spatial Expression Pattern 20%
• Temporal Expression Pattern 20%
• Well-differentiated Adenocarcinoma 20%
• Cognate Receptors 20%

Medicine and Dentistry

• Prostate Cancer 100%
• Angiogenesis 100%
• Adenocarcinoma 60%
• Platelet Endothelial Cell Adhesion Molecule 1 60%
• Neoplasm 40%
• Hypoxia 40%
• Fibrinogen 40%
• Tumor Progression 20%
• Receptor 20%
• Immunoblotting 20%
• Vascularity 20%
• Microvessel 20%
• Vasculotropin 20%
• Prostate Tissue 20%
• Antiangiogenic Therapy 20%

Biochemistry, Genetics and Molecular Biology

• Angiogenesis 100%
• Fibrinogen 66%
• Transgenics 66%
• Vascular Endothelial Growth Factor 33%
• Tumor Progression 33%
• Platelet 33%
• Immunoblotting 33%
• CD31 33%
• Vascularization 33%
• Cell Adhesion Molecule 1 33%